SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 226 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.86 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,171,725 | -8.3% | 42,500 | 0.0% | 0.06% | +31.2% |
| Q2 2023 | $1,277,550 | -17.0% | 42,500 | 0.0% | 0.05% | -15.8% |
| Q1 2023 | $1,539,775 | +1.6% | 42,500 | 0.0% | 0.06% | +7.5% |
| Q4 2022 | $1,515,975 | +36.1% | 42,500 | +29.2% | 0.05% | +20.5% |
| Q3 2022 | $1,114,000 | -97.6% | 32,900 | -98.9% | 0.04% | -94.6% |
| Q2 2022 | $46,562,000 | +4280.2% | 2,951,096 | +8869.9% | 0.82% | +2305.9% |
| Q1 2022 | $1,063,000 | +10.8% | 32,900 | 0.0% | 0.03% | +9.7% |
| Q4 2021 | $959,000 | +9.4% | 32,900 | 0.0% | 0.03% | +10.7% |
| Q3 2021 | $877,000 | -13.4% | 32,900 | 0.0% | 0.03% | -15.2% |
| Q2 2021 | $1,013,000 | – | 32,900 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 426,500 | $11,754,340 | 3.96% |
| ASHFORD CAPITAL MANAGEMENT INC | 916,747 | $25,274,715 | 3.72% |
| ARMISTICE CAPITAL, LLC | 5,092,000 | $140,386,440 | 2.15% |
| S&T BANK/PA | 215,578 | $5,943 | 1.15% |
| Aristotle Capital Boston, LLC | 1,187,981 | $32,752,634 | 1.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 544,468 | $15,010,983 | 0.95% |
| Tributary Capital Management, LLC | 352,429 | $9,716,468 | 0.92% |
| Bridge City Capital, LLC | 65,297 | $1,800,238 | 0.91% |
| Integral Health Asset Management, LLC | 220,000 | $6,065,400 | 0.84% |
| Retirement Planning Co of New England, Inc. | 51,608 | $1,422,833 | 0.79% |